Edition:
United Kingdom

Kaken Pharmaceutical Co Ltd (4521.T)

4521.T on Tokyo Stock Exchange

5,330JPY
17 Aug 2018
Change (% chg)

¥0 (+0.00%)
Prev Close
¥5,330
Open
¥5,300
Day's High
¥5,340
Day's Low
¥5,260
Volume
99,800
Avg. Vol
115,457
52-wk High
¥6,600
52-wk Low
¥5,260

Summary

Name Age Since Current Position

Tetsuo Ohnuma

67 2011 President, Representative Director

Hiroyuki Horiuchi

56 2018 Managing Director, Chief Director of Sales

Jun Takaoka

63 2016 Managing Director

Naoyuki Ishida

Executive Officer, Director of Human Resources

Jumpei Suzuki

2016 Executive Officer, Director of Accounting

Makoto Matsuura

Executive Officer, Director of Business Planning

Satoru Murakami

2018 Executive Officer, Manager of Pharmaceutical Manufacturing

Norihide Oizumi

Executive Officer, Manager of Production Office, Shizuoka Plant Manager

Chikara Ieda

57 2017 Chief Director of Research & Development, Director

Fumihiro Watanabe

58 2016 Director

Eiki Enomoto

49 2014 Non-Executive Independent Director

Yoshio Tanabe

63 2016 Non-Executive Independent Director

Biographies

Name Description

Tetsuo Ohnuma

Mr. Tetsuo Ohnuma has been serving as President and Representative Director in Kaken Pharmaceutical Co., Ltd. since June 2011. He joined the Company in April 1974. His previous titles include Director of Sales Planning, Executive Officer, Managing Director and Chief Director of Sales in the Company.

Hiroyuki Horiuchi

Mr. Hiroyuki Horiuchi has been serving as Managing Director and Chief Director of Sales in Kaken Pharmaceutical Co., Ltd. since June 2018. He joined the Company in April 1984. His previous titles include Executive Officer, Manager of Chugoku & Shikoku Office and Manager of Osaka Office in the Company.

Jun Takaoka

Mr. Jun Takaoka has been serving as Managing Director in Kaken Pharmaceutical Co., Ltd. since June 2016. He used to work for The Norinchukin Bank, Nihon Unisys, Ltd. and Okasan Securities Co., Ltd.

Naoyuki Ishida

Jumpei Suzuki

Makoto Matsuura

Satoru Murakami

Norihide Oizumi

Chikara Ieda

Mr. Chikara Ieda has been serving as Chief Director of Research & Development and Director in Kaken Pharmaceutical Co., Ltd. since June 2017. He joined the Company in April 1984. His previous titles include Director of Clinical Development, Director of Expansion Planning, Director of Development Portfolio Promotion and Executive Officer in the Company.

Fumihiro Watanabe

Mr. Fumihiro Watanabe has been serving as Director in Kaken Pharmaceutical Co., Ltd. since June 2016. He joined the Company in April 2000. His previous titles include Executive Officer, Director of General Affairs and Director of Accounting in the Company. He used to work for Toho Mutual Life Insurance Company.

Eiki Enomoto

Mr. Eiki Enomoto has been serving as Non-Executive Independent Director in Kaken Pharmaceutical Co., Ltd. since June 27, 2014. He is also serving as Partner in a Japan-based law firm as well as working for Supreme Court of Japan. He used to work for Zenrin Company, Limited.

Yoshio Tanabe

Mr. Yoshio Tanabe has been serving as Non-Executive Independent Director in Kaken Pharmaceutical Co., Ltd. since June 2016. He is also serving as Representative Director in MedicalOpinion CO.,LTD., as well as Partner in KIZASHI Co., Ltd. He used to work for McKinsey & Company, Inc., Otsuka Pharmaceutical Co., Ltd. and TOKUHON Corporation.